Juliet L. Rogers, PhD, MPH, is relentlessly pursuing new models for healthcare delivery and promotion of healthy populations while serving as CEO of Blue Cottage Consulting. With significant experience and expertise in complex hospital systems, her areas of focus include large public hospitals, academic medical centers, and children's hospitals. She also co-founded and leads a research coalition conducting multi-year studies to assess the impact of facility design on operations and clinical outcomes in large, urban hospitals.
Dr. Rogers is an advisor and planning consultant to healthcare systems throughout the U.S. and Canada, specifically those looking to transform healthcare or expand into new service areas. She draws from deep experience gained through service in key leadership positions throughout her health care career. On the academic side, Juliet spent several years on the faculty in the Department of Health Management and Policy at the University of Michigan School of Public Health, where her research and teaching interests focused on the organization and delivery of healthcare, practical innovation and design thinking, and the role of the healthcare safety net in the U.S.
Prior to joining the faculty, Dr. Rogers served as Associate Hospital Administrator at the University of Michigan Health System and Director of the Women's Health Program. She earned her Bachelor of Arts in Political Science, her Master's in Public Health, and her Doctorate in Health Services Organization and Policy from the University of Michigan in Ann Arbor. Juliet’s doctoral preparation and research was completed with support from the Ruth L. Kirschstein National Research Service Award.
David Prendergast is a social anthropologist and Professor of Science, Technology and Society at Maynooth University in Ireland where he is currently Head of the Department of Design Innovation. Previously David worked at Intel where he was a Principal Investigator at the ‘Technology Research for Independent Living Centre’ and co-founder of the ‘Intel Institute for Sustainable Connected Cities’. He has also served as Visiting Professor of Healthcare Innovation at the School of Nursing and Midwifery at Trinity College Dublin. His latest book ‘Aging and the Digital Life Course’ was named a CHOICE ‘Outstanding Academic Title’ by the American Library Association and was described as one of ‘the two most fascinating books on aging in the 21st Century’ by the Huffington Post.
Peter Robbins is one of Ireland’s foremost experts in innovation and new product and service development. He was global head of innovation excellence for GlaxoSmithKline where he led many of the worldwide, new product launches for Lucozade, Aquafresh, Sensodyne, Panadol, Ribena, alli and NiQuitin. Peter’s PhD is in Innovation. His area of research is how firms organise for innovation. He is a former head of the Department of Design Innovation in Maynooth University. He is a member of the Government's National Design Forum and has developed and run courses and workshops in innovation for organisations in the public and private sector. He is on a number of innovation advisory boards in business and the third sector. Peter has trained in the renowned Stanford D School, he is a graduate of London’s What-if creativity programme. He has published in R&D Management, the Irish Journal of Management: International Journal of Innovation Management; London Strategy Review and regularly speaks at international conferences on the subject of managing creativity and innovation
Laura Magahy has led some of Ireland’s most significant and transformational public-sector projects on behalf of government including the €1 billion urban renewal of Temple Bar and the Global Irish Forum initiative, Irish Design 2015.
She has led change management and physical development projects in healthcare and has a particular interest in population-based planning and citizen engagement.
Laura Magahy is a Fellow and past President of the Institute of Directors and is one of Ireland’s top Level A Project Directors. She is an honorary member of the Royal Institute of Architects in Ireland and has served on numerous public, private and plc boards as Chairman, Non-Executive Director, and Executive Director.
Trevor Vaugh is faculty at Maynooth University and the director of the award-winning Masters in Design Innovation (MScDI). Trevor is as expert in Design-driven innovation process, and he regularly works with public and private organisations in this area. Prior to entering academia, Trevor helped develop a number of disruptive surgical innovations, and with a portfolio of over 45 patents he is one of the most active inventors in the country. His ground-breaking work on the development of scarless surgery for Olympus, helped see it recognised as one of the Cleveland clinic's top 10 innovations of 2009.
As a partner and founder of the innovation consultancy Actionable, he helps clients understand the role of design as an agent of discovery, change and a mediator between humanity and technology. In the past number of years he has delivered consultancy and mentoring for clients such as Olympus, Boston scientific, Openet, Musgraves, the IDA and delivered programmes for Irish Times training, the AIB start-up academy and the IRDG. Trevor is a board member and co-editor of Iterations design journal. In both his academic and practitioner roles, he champions the interdisciplinary nature of design, and applies design thinking and action research to areas such as business, education, policy and healthcare.
Dr O’Mahony is an assistant research professor at the Centre for Health Policy and Management at Trinity College Dublin. He is employed under a HRB Emerging Investigator Award. He has been part of the CERVIVA research consortium since 2013. James is an economist by training and his research addresses the cost-effectiveness analysis (CEA) of cancer prevention, primarily concerning cervical screening. His research interests are in CEA methods in general, simulation modelling and the use of CEA evidence by decision makers. James has a particular interest in the extent to which cost-effectiveness evidence is disregarded by policy makers and the negative impact this has on population health in Ireland.
Dr Niamh Humphries is a Reader in Health Systems Research at the Royal College of Physicians of Ireland and holder of a HRB Emerging Investigator Award for the Hospital Doctor Retention and Motivation (HDRM) project. She holds a Degree and PhD in Sociology from University College Dublin and a Masters from Trinity College Dublin. She has been researching health worker migration for the past 12 years– from the inward migration of internationally trained nurses and doctors to Ireland, to a more recent focus on the emigration of Irish trained doctors from Ireland. She was Co-PI of the HRB Doctor Emigration Project (2013-6) and PI of the Failure to Retain Project (2014-5). She will be presenting initial findings from the first phase of the HDRM project, which focusses on the emigration of Irish trained doctors to Australia.
Dr. Ferguson is a Senior Research Fellow in Biostatistics at National University of Ireland Galway. He has a PhD. in statistics from Yale University (2009) and has 35 peer-reviewed publications in biostatistics methodology and applications. He is a recent recipient of a HRB emerging investigator award. His research interests focus on the development and application of probabilistic graphical models and methods in causal statistics.
Dr Jane English is a Lecturer in Department of Anatomy and Neuroscience, UCC, and a HRB funded Principle Investigator at INFANT Research Centre, UCC. Jane is a recipient of a HRB Emerging Investigator Award which has facilitated the establishment of a Biomarker Discovery Programme in Autism Spectrum Disorder at INFANT. Her research interests are in the application of Proteomics, Metabolomics, and Bioinformatics approaches to study the underlying biological processes implicated in disease, with a particular focus on neurodevelopmental and neuropsychiatric disorders.
Darrin Morrissey took up the position of Chief Executive at the Health Research Board in July 2018.
Immediately before joining the HRB, Darrin was the Director of Programmes and Investments with Science Foundation Ireland, where he led the delivery of funding to science & technology research across the Irish public sector research institutions. With SFI Darrin played a leading role in the delivery of the SFI Research Centres; large-scale public-private partnerships that have delivered exceptional economic and scientific impact nationally and internationally. He also led an increased orientation of SFI’s funding programmes towards the evolving needs of industry and the broadening of SFI’s portfolio of international funding partnerships.
Darrin’s prior experience includes 16 years spanning research, manufacturing and commercial success in the pharmaceutical and biotech industries. In a variety of roles in companies including GSK and Sanofi, Darrin’s work ranged from leading the development of the GSK oncology business in Ireland, to managing clinical trials across various therapy areas, and from developing and delivering national and international business strategies, to the launch of melanoma other oncology products on global markets.
Darrin qualified with a BSc in Microbiology and he holds a PhD from University College Cork. His PhD research focused on the molecular mechanisms that underlie the spread of cancer. He also worked as a postdoctoral researcher at UCC, where he managed ‘first-in-human’ clinical trials of food products affecting the gut microbiome. Darrin also holds a Diploma in Advanced Management awarded by National University of Ireland Galway.
Over recent years Darrin has been a member of a wide range of national development policy groups, including the Life Sciences Alliance, the Smart Ageing Steering Group, the Knowledge Transfer Ireland Stakeholder Forum and the British Irish Chamber of Commerce Higher Education & Research Steering Group.